Market research reports, consulting: Global Market Insights Inc.

Home > Healthcare > Pharmaceuticals > Finished Drug Form > biological skin substitutes market

Biological Skin Substitutes Market Share

Report ID: GMI6964 Published Date: October 2023Report Format: PDF
Download Free Sample
Summary
Table of Content

Biological Skin Substitutes Market Share

The biological skin substitutes industry is consolidated, with major players such as Mylan N.V., Misonix, Inc., and others dominating the market. These companies are focused on continuous product innovation to secure a significant market share. For instance, Misonix is known for its Theraskin product, which is a biosynthetic skin substitute that combines synthetic materials with biological components to promote wound healing.

Some of the eminent market participants operating in the biological skin substitutes industry include:

  • Organogenesis Inc
  • Smith & Nephew plc
  • MiMedx Group, Inc.
  • Misonix, Inc. (Bioventus)
  • Avita Medical
  • Stratatech Corporation (Mallinckrodt Pharmaceuticals)
  • BioTissue
  • Aroa Biosurgery
  • ProgenaCare
  • Mimedx Group (MiMedx Group, Inc.)
  • Tissue Regenix
  • Stryker
  • Vericel Corporation
  • Integra LifeSciences
Author: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :

How are acute wounds contributing to the biological skin substitutes industry?+

The acute wounds application segment accounted for over 59% share of the biological skin substitutes market in 2022 owing to advantages, such as higher incidence, immediate treatment requirements, and positive clinical outcomes.

Why are human donor tissue-derived biological skin substitutes gaining prominence?+

The human donor tissue-derived products segment reached USD 188 million in 2022 attributed to advantages, such as exceptional biological compatibility, proven safety record, and established efficacy.

How big is the biological skin substitutes market?+

Biological skin substitutes industry size reached USD 287 million in 2022 and is estimated to record USD 640 million by 2032 due to higher adoption for replacing or regenerating damaged or lost skin tissue

What factors are driving the U.S. biological skin substitutes industry growth?+

Demand for biological skin substitutes in the U.S. reached USD 109 million in 2022 and is predicted to witness substantial growth through 2032 attributed to the annual increase in burn injuries in the nation

Biological Skin Substitutes Market Scope

Related Reports

Buy Now

Premium Report Details

Download Free Sample